Morrow, Jarrett D.
Cho, Michael H.
Platig, John
Zhou, Xiaobo
DeMeo, Dawn L.
Qiu, Weiliang
Celli, Bartholome
Marchetti, Nathaniel
Criner, Gerard J.
Bueno, Raphael
Washko, George R.
Glass, Kimberly
Quackenbush, John
Silverman, Edwin K.
Hersh, Craig P.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K25 HL136846, P01 HL105339, R01 HL111759, R01 HL125583, R01 HL130512, P01 HL132825, R01 HL089856, R01 HL089897, K25 HL133599)
Article History
Received: 20 September 2017
Accepted: 2 January 2018
First Online: 15 January 2018
Ethics approval and consent to participate
: Subjects provided written informed consent for the use of excess lung tissue for research. IRB approval was obtained at Partners Healthcare (parent company of Brigham and Women’s Hospital), Temple University, and St. Elizabeth’s Hospital. The methods for lung tissue research were carried out in accordance with the relevant guidelines.
: Drs. Morrow, Platig, Zhou, Qiu, Marchetti, Criner, Celli, Glass, Quackenbush report no competing interests related to this manuscript.Dr. Cho has received compensation from GSK.Dr. DeMeo has received compensation from Novartis.Dr. Bueno has received compensation from Myriad Genetics, Inc., Siemens, Verastem, Inc., Genentech, Inc., Gritstone Oncology, Inc., HTG Molecular Diagnostics, Inc., Neil Leifer, Esq, Morrison Mahoney, David Weiss, LLC, Balick & Balick, LLC, Hartford Hospital, Cleveland Clinic/Conference, Aspen Lung Conference, Case Western Reserve, North Shore University, Castle Bioscience, Novartis Institutes for Biomedical Research, AstraZebeca, imCORE/Roche, Arthur Tuverson, LLC, Ferraro Law Firm, Rice Dolan & Kershaw, Satterly & Kelly, LLC, Exosome, Inc.Dr. Washko has received compensation from Boehringer Ingelheim, GlaxoSmithKline, Janssen Pharmaceuticals, BTG Interventional Medicine, Regeneron, Quantitative Imaging Solutions and ModoSpira, and his Spouse works for Biogen.Dr. Silverman has received compensation from COPD Foundation, GlaxoSmithKline, Merck and Novartis,Dr. Hersh has received consulting fees from AstraZeneca, Concert Pharmaceuticals, Mylan, and grant support from Boehrinher Ingelheim.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.